Search
for
Sort by
Research 30 of 270
- 612 Wnt signaling induces fibrotic fat loss via DPP4 in skin fibrosis
- 557 A peptide derivative with known anti-wrinkle properties was identified as potent dipeptiylpeptidase-4 inhibitor
- DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice
- Linagliptin-Associated Alopecia and Bullous Pemphigoid
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Alopecia areata universalis nach Sitagliptin-Einnahme
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- 613 Bacteria induce skin regeneration via IL-1β signaling
- Repurposing DPP4-Inhibition to Improve Hair Follicle Activation and Regeneration
- 973 Dipeptidyl-peptidase 4 (DPP4)-positive fibroblasts are responsible for secretion of pro-fibrotic matrix proteins in the human skin
- Inhibiting dipeptidyl peptidase 4 positive fibroblasts using zinc sulfide cellulose nanofiber scaffolds to achieve scarless healing
- Fibroblasts – the cellular choreographers of wound healing
- Hair Growth Promoting Effects of 15-Hydroxyprostaglandin Dehydrogenase Inhibitor in Human Follicle Dermal Papilla Cells
- 15-Hydroxyprostaglandin Dehydrogenase Inhibitor Restores Endothelial Function Under Dihydrotestosterone-Induced Stress in Human Dermal Microvascular Endothelial Cells
- Teneligliptin-induced hair loss: A case report
- Hair Growth-Promoting Effects of a Multi-Targeted Cosmetic Formulation Containing PYGL, DP2, and 15-PGDH Inhibitors Developed Using AI-Based DeepZema® in Androgenetic Alopecia: A 24-Week Randomized Controlled Trial
- Tissue fibrosis associated depletion of lipid‐filled cells
- Two-Stage Machine Learning-Based GWAS for Wool Traits in Central Anatolian Merino Sheep
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- Farmácia Azevedo Carvalho, Cabeceiras de Bastos
- Wound Healing: A Cellular Perspective
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- CXCL12 inhibits hair growth through CXCR4
- Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations